Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP263811.RA2AXfsWQpQ_1IwX1zoSAbUHbPdaLa_SmilCojBKFo7Lo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP263811.RA2AXfsWQpQ_1IwX1zoSAbUHbPdaLa_SmilCojBKFo7Lo130_assertion type Assertion NP263811.RA2AXfsWQpQ_1IwX1zoSAbUHbPdaLa_SmilCojBKFo7Lo130_head.
- NP263811.RA2AXfsWQpQ_1IwX1zoSAbUHbPdaLa_SmilCojBKFo7Lo130_assertion description "[To determine the antitumor effect of arsenic trioxide (As2O3) on multidrug-resistant cells, we applied 3 human leukemia cell lines: daunorubicin (DNR)-resistant cell line K562/D1-9, which overexpresses p-glycoprotein (Pgp); DNR and 1-beta-D-arabinofuranosylcytosine (Ara-C) double-resistant cell line HL60/AD, which overexpresses multidrug resistance-associated protein (MRP1); and Bcl-2-transfected pre-B lineage leukemia cell line 697/Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263811.RA2AXfsWQpQ_1IwX1zoSAbUHbPdaLa_SmilCojBKFo7Lo130_provenance.
- NP263811.RA2AXfsWQpQ_1IwX1zoSAbUHbPdaLa_SmilCojBKFo7Lo130_assertion evidence source_evidence_literature NP263811.RA2AXfsWQpQ_1IwX1zoSAbUHbPdaLa_SmilCojBKFo7Lo130_provenance.
- NP263811.RA2AXfsWQpQ_1IwX1zoSAbUHbPdaLa_SmilCojBKFo7Lo130_assertion SIO_000772 15868938 NP263811.RA2AXfsWQpQ_1IwX1zoSAbUHbPdaLa_SmilCojBKFo7Lo130_provenance.
- NP263811.RA2AXfsWQpQ_1IwX1zoSAbUHbPdaLa_SmilCojBKFo7Lo130_assertion wasDerivedFrom befree-20150227 NP263811.RA2AXfsWQpQ_1IwX1zoSAbUHbPdaLa_SmilCojBKFo7Lo130_provenance.
- NP263811.RA2AXfsWQpQ_1IwX1zoSAbUHbPdaLa_SmilCojBKFo7Lo130_assertion wasGeneratedBy ECO_0000203 NP263811.RA2AXfsWQpQ_1IwX1zoSAbUHbPdaLa_SmilCojBKFo7Lo130_provenance.